De nieren verwijderen afvalstoffen en bepalen de mineraalbalans. Nierdisfunctie heeft een grote impact op het lichaam, in zoverre zelfs dat patiënten niet zozeer aan nierdisfunctie ten onder gaan, wel aan hart- en vaatziekte en andere complicaties. Nierdisfunctie veroorzaakt uremie, ontsteking, oxidatieve stress, hormonale ontregelingen, anorexie en dysbiose. Inname van calorieën, vezels, proteïne, fosfaat, calcium, kalium, magnesium, vitamine D en vitamine K moet goed op elkaar afgestemd worden. Dit overzicht heeft enkel betrekking op niet-dialytische nierpatiënten.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Verschenen in
Referenties
Kalantar-Zadeh K, Tortorici AR et al. Dietary restrictions in dialysis patients: is there anything left to eat? Semin Dial. 2015 Mar-Apr;28(2):159-68
Anderson CA, Nguyen HA, Rifkin DE. Nutrition interventions in chronic kidney disease. Med Clin North Am. 2016 Nov;100(6):1265-1283. doi: 10.1016/j.mcna.2016.06.008. Epub 2016 Sep 13.
Alhosaini M, Leehey DJ. Magnesium and dialysis: the neglected cation. Am J Kidney Dis. 2015 Sep;66(3):523-31
DASH (Dietary Approaches to Stop Hypertension) diet and risk of subsequent kidney disease. Am J Kidney Dis. 2016;68(6):853-861
Gallieni M, Cupisti A. DASH and mediterranean diets as nutritional interventions for CKD patients. Am J Kidney Dis. 2016 Dec;68(6):828-830.
el Nahas AM, Coles GA. Dietary treatment of chronic renal failure: ten unanswered questions. Lancet. 1986 Mar 15;1(8481):597-600
Piccoli GB, Capizzi I, Vigotti FN et al. Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines? BMC Nephrol. 2016 Jul 8;17(1):76
Shah BV, Patel ZM. Role of low protein diet in management of different stages of chronic kidney disease - practical aspects. BMC Nephrol. 2016 Oct 21;17(1):156
Bellizzi V, Cupisti A, Locatelli F et al. Low-protein diets for chronic kidney disease patients: the Italian experience. BMC Nephrol. 2016 Jul 11;17(1):77
Watanabe S. Low-protein diet for the prevention of renal failure. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(1):1-9
Wiederkehr M, Krapf R. Metabolic and endocrine effects of metabolic acidosis in humans. Swiss Med Wkly. 2001 Mar 10;131(9-10):127-32
Di Iorio BR, Di Micco L, Marzocco S et al. Very low-protein diet (VLPD) reduces metabolic acidosis in subjects with chronic kidney disease: The "Nutritional Light Signal" of the renal acid load. Nutrients. 2017 Jan 17;9(1). pii: E69
Schwingshackl L, Hoffmann G. Comparison of high vs. normal/low protein diets on renal function in subjects without chronic kidney disease: a systematic review and meta-analysis. PLoS One. 2014 May 22;9(5):e97656
Jiang Z, Zhang X et al. Effect of restricted protein diet supplemented with keto analogues in chronic kidney disease: a systematic review and meta-analysis. Int Urol Nephrol. 2016 Mar;48(3):409-18
Vanholder R, Fouque D, Glorieux G et al. Clinical management of the uraemic syndrome in chronic kidney disease. Lancet Diabetes Endocrinol. 2016 Apr;4(4):360-73
Kovesdy CP, Kalantar-Zadeh K. Back to the future: restricted protein intake for conservative management of CKD, triple goals of renoprotection, uremia mitigation, and nutritional health. Int Urol Nephrol. 2016 May;48(5):725-9
Chan M, Kelly J, Batterham M, Tapsell L. A high prevalence of abnormal nutrition parameters found in predialysis end-stage kidney disease: is it a result of uremia or poor eating habits? J Ren Nutr. 2014 Sep;24(5):292-302
Musso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol. 2015 Nov;47(11):1801-7
Hirai K, Ookawara S, Morishita Y. Sarcopenia and physical inactivity in patients with chronic kidney disease. Nephrourol Mon. 2016 Apr 26;8(3):e37443
Kittiskulnam P, Carrero JJ, Chertow GM et al. Sarcopenia among patients receiving hemodialysis: weighing the evidence. J Cachexia Sarcopenia Muscle. 2016 Aug 11. doi: 10.1002/jcsm.12130
Jing Z, Wei-Jie Y. Effects of soy protein containing isoflavones in patients with chronic kidney disease: A systematic review and meta-analysis. Clin Nutr. 2016 Feb;35(1):117-24
Kuczera P, Adamczak M, Wiecek A. Fibroblast Growth Factor-23-A Potential Uremic Toxin. Toxins (Basel). 2016 Dec 8;8(12). pii: E369
Langman CB, Cannata-Andía JB. Calcium in chronic kidney disease: myths and realities. Introduction. Clin J Am Soc Nephrol. 2010 Jan;5 Suppl 1:S1-2
Isakova T, Ix JH, Sprague SM et al. Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD. J Am Soc Nephrol. 2015 Oct;26(10):2328-39
Taketani Y, Koiwa F, Yokoyama K. Management of phosphorus load in CKD patients. Clin Exp Nephrol. 2017 Mar;21(Suppl 1):27-36
Cannata-Andía JB, Martin KJ. The challenge of controlling phosphorus in chronic kidney disease. Nephrol Dial Transplant. 2016 Apr;31(4):541-7
Kalaitzidis RG, Duni A, Siamopoulos KC. Klotho, the Holy Grail of the kidney: from salt sensitivity to chronic kidney disease. Int Urol Nephrol. 2016 Oct;48(10):1657-66
Neyra JA, Hu MC. Potential application of klotho in human chronic kidney disease. Bone. 2017 Jan 20. pii: S8756-3282(17)30017-0
El Borolossy R, El Wakeel LM et al. Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis. Pediatr Nephrol. 2016 Feb;31(2):289-96
Teo HK, Wong J. Unusual cause of hypercalcaemia in end stage renal failure patients. Hemodial Int. 2016 Nov 20. doi: 10.1111/hdi.12512
Liu WC, Wu CC, Hung YM et al. Pleiotropic effects of vitamin D in chronic kidney disease. Clin Chim Acta. 2016 Jan 30;453:1-12
Weiner DE, Kapoian T, Johnson DS. Nutrition, vitamin D, and health outcomes in hemodialysis: time for a feeding frenzy? Curr Opin Nephrol Hypertens. 2015 Nov;24(6):546-56
McCabe KM, Adams MA, Holden RM. Vitamin K status in chronic kidney disease. Nutrients. 2013 Nov 7;5(11):4390-8
Kurnatowska I, Grzelak P, Masajtis-Zagajewska A et al. Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5. Pol Arch Med Wewn. 2015;125(9):631-40
Shigematsu T, Sonou T et al. Preventive strategies for vascular calcification in patients with chronic kidney disease. Contrib Nephrol. 2017;189:169-177
Chen Z, Qureshi AR, Parini P et al. Does statins promote vascular calcification in chronic kidney disease? Eur J Clin Invest. 2017 Feb;47(2):137-148. doi: 10.1111/eci.12718
Genovesi S, Gallieni M. Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks? Expert Opin Drug Saf. 2014 Sep;13(9):1143-8
Chiavaroli L, Mirrahimi A et al. Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr. 2015 Jul;69(7):761-8
Salmean YA, Segal MS, Palii SP et al. Fiber supplementation lowers plasma p-cresol in chronic kidney disease patients. J Ren Nutr. 2015 May;25(3):316-20
Koppe L, Mafra D, Fouque D. Probiotics and chronic kidney disease. Kidney Int. 2015 Nov;88(5):958-66
Nallu A, Sharma S, Ramezani A et al. Gut microbiome in chronic kidney disease: challenges and opportunities. Transl Res. 2017 Jan;179:24-37
Rhee EP, Clish CB, Ghorbani A et al. A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol. 2013 Jul;24(8):1330-8
Ramezani A, Massy ZA et al. Role of the gut microbiome in uremia: A potential therapeutic target. Am J Kidney Dis. 2016 Mar;67(3):483-98
Ikizler TA. Nutrition, inflammation and chronic kidney disease. Curr Opin Nephrol Hypertens. 2008 Mar;17(2):162-7
Gondouin B, Jourde-Chiche N, Sallee M et al. Plasma xanthine oxidase activity is predictive of cardiovascular disease in patients with chronic kidney disease, independently of uric acid levels. Nephron. 2015;131(3):167-74
Krishnamurthy A, Lazaro D, Stefanov DG et al. The effect of allopurinol on renal function. J Clin Rheumatol. 2017 Jan;23(1):1-5
Clarke RE, Dordevic AL, Tan SM et al. Dietary advanced glycation end products and risk factors for chronic disease: A systematic review of randomised controlled trials. Nutrients. 2016 Mar 1;8(3):125
Meeusen J. Advanced glycation endproducts. Waarom suiker toxisch is. Arts Therapeut & Apotheker. 2011;12(2)
Jalal DI, Chonchol M, Chen W et al. Uric acid as a target of therapy in CKD. Am J Kidney Dis. 2013 Jan;61(1):134-46
Coombes JS, Fassett RG. Antioxidant therapy in hemodialysis patients: a systematic review. Kidney Int. 2012 Feb;81(3):233-46
Daud ZA, Tubie B, Sheyman M et al. Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients. Vasc Health Risk Manag. 2013;9:747-61
Himmelfarb J, Ikizler TA, Ellis C et al. Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial. J Am Soc Nephrol. 2014 Mar;25(3):623-33
Ramos LF, Kane J, McMonagle E et al. Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. J Ren Nutr. 2011 May;21(3):211-8
Himmelfarb J, Phinney S et al. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. J Ren Nutr. 2007 Sep;17(5):296-304
Sahebkar A, Cicero AF et al. Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2016 May;107:234-42
Derosa G, Maffioli P et al. Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2016 Sep;111:394-404.
Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res. 2014 May;28(5):633-42
Saboori S, Shab-Bidar S, Speakman JR et al. Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2015 Aug;69(8):867-73
Sahni N, Gupta KL, Rana SV et al. Intake of antioxidants and their status in chronic kidney disease patients. J Ren Nutr. 2012 Jul;22(4):389-99
L Gupta K, Sahni N. Dietary antioxidents and oxidative stress in predialysis chronic kidney disease patients. J Nephropathol. 2012 Oct;1(3):134-42
Jun M, Venkataraman V, Razavian M et al. Antioxidants for chronic kidney disease. Cochrane Database Syst Rev. 2012 Oct 17;10:CD008176
Dupont JJ, Farquhar WB, Townsend RR et al. Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease. J Appl Physiol (1985). 2011 Dec;111(6):1561-7
Sabri MR, Tavana EN, Ahmadi A et al. Effect of vitamin C on endothelial function of children with chronic renal failure: An experimental study. Adv Biomed Res. 2015 Dec 31;4:260
Ruiz S, Pergola PE, Zager RA et al. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013 Jun;83(6):1029-41
Saran R, Novak JE, Desai A et al. Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study. Nephrol Dial Transplant. 2003 Nov;18(11):2415-20
Mas E, Barden A, Burke V et al. A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease. Clin Nutr. 2016 Apr;35(2):331-6
Barden AE, Burke V, Mas E et al. n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease. Hypertens. 2015 Sep;33(9):1947-53
Cupisti A, D'Alessandro C, Fumagalli G et al. Nutrition and physical activity in CKD patients. Kidney Blood Press Res. 2014;39(2-3):107-13
Moinuddin I, Leehey DJ. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Adv Chronic Kidney Dis. 2008 Jan;15(1):83-96
Webster A, Palmer S et al. Statins for chronic kidney disease not requiring dialysis. Nephrology (Carlton). 2015 Apr;20(4):300-1
Sharma S, McFann K, Chonchol M et al. Association between dietary sodium and potassium intake with chronic kidney disease in US adults: a cross-sectional study. Am J Nephrol. 2013;37(6):526-33
Sarafidis PA, Georgianos PI, Bakris GL. Advances in treatment of hyperkalemia in chronic kidney disease. Expert Opin Pharmacother. 2015;16(14):2205-15
Wang HH, Hung CC, Hwang DY et al. Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease. PLoS One. 2013 Jul 2;8(7):e67140
Humalda JK, Navis G. Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens. 2014 Nov;23(6):533-40
McMahon EJ, Bauer JD et al. A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol. 2013 Dec;24(12):2096-103
van Zuilen AD, Bots ML, Dulger A et al. Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease. Kidney Int. 2012 Sep;82(6):710-7
M de Francisco AL1, Rodríguez M. Magnesium - its role in CKD. Nefrologia. 2013;33(3):389-99
Dousdampanis P, Trigka K, Fourtounas C. Hypomagnesemia, chronic kidney disease and cardiovascular mortality: pronounced association but unproven causation. Hemodial Int. 2014 Oct;18(4):730-9
Kanbay M1, Goldsmith D, Uyar ME et al. Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif. 2010;29(3):280-92
Javed RA, Marrero K, Rafique M et al. Life-threatening hyperkalaemia developing following excessive ingestion of orange juice in a patient with baseline normal renal function. Singapore Med J. 2007 Nov;48(11):e293-5
Palmer BF, Clegg DJ. Achieving the benefits of a high-potassium, paleolithic diet, without the toxicity. Mayo Clin Proc. 2016 Apr;91(4):496-508
Rebholz CM, Coresh J, Grams ME et al. Dietary acid load and incident chronic kidney disease: Results from the ARIC Study. Am J Nephrol. 2015;42(6):427-35
Tanemoto M, Ishimoto Y, Saito H. Oral low-dose ferric citrate is a useful iron source for hyperphosphatemic hemodialysis patients: a case series. Blood Purif. 2016 Dec 13;43(1-3):97-100
Fishbane S, Block GA et al. Effects of ferric citrate in patients with nondialysis-dependent CKD and iron deficiency anemia. J Am Soc Nephrol. 2017 Jan 12. pii: ASN.2016101053
Block GA, Fishbane S, Rodriguez M et al. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5. Am J Kidney Dis. 2015 May;65(5):728-36
Katai K, Iwamoto A, Kimura Y et al. Wakame (Undaria pinnatifida ) modulates hyperphosphatemia in a rat model of chronic renal failure. J Med Invest. 2015;62(1-2):68-74
Zhang X, Lerman LO. The metabolic syndrome and chronic kidney disease. Transl Res. 2016 Dec 9. pii: S1931-5244(16)30424-8
Lobo JC, Aranha LN, Moraes C et al. Linking zinc and leptin in chronic kidney disease: future directions. Biol Trace Elem Res. 2012 Apr;146(1):1-5
Takahashi N, Morimoto S, Okigaki M et al. Decreased plasma level of vitamin C in chronic kidney disease: comparison between diabetic and non-diabetic patients. Nephrol Dial Transplant. 2011 Apr;26(4):1252-7
Timmer S. Vegetarisme oké, maar veganisme? Arts Therapeut & Apotheker. 2016; 17(1)
Muskiet F. Eten we teveel zout (natrium)? Een holistische kijk op onze Na-K-Ca-Mg en zuur/base balans. Ned Tijdschr Klin Chem Labgeneesk 2015; 40: 164-193